0000899243-21-034820.txt : 20210901
0000899243-21-034820.hdr.sgml : 20210901
20210901195622
ACCESSION NUMBER: 0000899243-21-034820
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210830
FILED AS OF DATE: 20210901
DATE AS OF CHANGE: 20210901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Claremount VII Associates, L.P.
CENTRAL INDEX KEY: 0001841808
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40154
FILM NUMBER: 211231438
BUSINESS ADDRESS:
STREET 1: 295 LAFAYETTE STREET
CITY: NEW YORK
STATE: NY
ZIP: 10012
BUSINESS PHONE: 646-680-0240
MAIL ADDRESS:
STREET 1: 295 LAFAYETTE STREET
CITY: NEW YORK
STATE: NY
ZIP: 10012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Thrive Capital Partners VII Growth, L.P.
CENTRAL INDEX KEY: 0001841736
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40154
FILM NUMBER: 211231440
BUSINESS ADDRESS:
STREET 1: 295 LAFAYETTE STREET
CITY: NEW YORK
STATE: NY
ZIP: 10012
BUSINESS PHONE: 646-680-0240
MAIL ADDRESS:
STREET 1: 295 LAFAYETTE STREET
CITY: NEW YORK
STATE: NY
ZIP: 10012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Thrive Partners VII Growth GP, LLC
CENTRAL INDEX KEY: 0001877735
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40154
FILM NUMBER: 211231441
BUSINESS ADDRESS:
STREET 1: 295 LAFAYETTE STREET
CITY: NEW YORK
STATE: NY
ZIP: 10012
BUSINESS PHONE: (646) 680-0240
MAIL ADDRESS:
STREET 1: 295 LAFAYETTE STREET
CITY: NEW YORK
STATE: NY
ZIP: 10012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Thrive Partners VII GP, LLC
CENTRAL INDEX KEY: 0001877733
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40154
FILM NUMBER: 211231439
BUSINESS ADDRESS:
STREET 1: 295 LAFAYETTE STREET
CITY: NEW YORK
STATE: NY
ZIP: 10012
BUSINESS PHONE: (646) 680-0240
MAIL ADDRESS:
STREET 1: 295 LAFAYETTE STREET
CITY: NEW YORK
STATE: NY
ZIP: 10012
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oscar Health, Inc.
CENTRAL INDEX KEY: 0001568651
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 VARICK STREET
STREET 2: 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10013
BUSINESS PHONE: (646) 403-3677
MAIL ADDRESS:
STREET 1: 75 VARICK STREET
STREET 2: 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10013
FORMER COMPANY:
FORMER CONFORMED NAME: Mulberry Health Inc.
DATE OF NAME CHANGE: 20130204
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-08-30
0
0001568651
Oscar Health, Inc.
OSCR
0001877735
Thrive Partners VII Growth GP, LLC
C/O THRIVE CAPITAL, 295
LAFAYETTE STREET, SUITE 701
NEW YORK
NY
10012
0
0
1
0
0001841736
Thrive Capital Partners VII Growth, L.P.
C/O THRIVE CAPITAL,
295 LAFAYETTE STREET, SUITE 701
NEW YORK
NY
10012
0
0
1
0
0001877733
Thrive Partners VII GP, LLC
C/O THRIVE CAPITAL,
295 LAFAYETTE STREET, SUITE 701
NEW YORK
NY
10012
0
0
1
0
0001841808
Claremount VII Associates, L.P.
C/O THRIVE CAPITAL,
295 LAFAYETTE STREET, SUITE 701
NEW YORK
NY
10012
0
0
1
0
Class A Common Stock
2021-08-30
4
P
0
274697
14.6844
A
1997676
I
See footnote
Class A Common Stock
2021-08-30
4
P
0
55188
15.2709
A
2052864
I
See footnote
Class A Common Stock
2021-08-31
4
P
0
93836
14.8116
A
2146700
I
See footnote
Class A Common Stock
2021-08-31
4
P
0
211703
15.4328
A
2358403
I
See footnote
Represents (i) 271,427 shares purchased by Thrive Capital Partners VII Growth, L.P. ("Thrive VII Growth") and (ii) 3,270 shares purchased by Claremount VII Associates, L.P. ("Claremount VII"). The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $14.12 to $15.11, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected. All shares were purchased in accordance with the daily volume and other limitations and requirements of Rule 10b-18. Following the reported transaction, 1,973,894 shares are held directly by Thrive VII Growth and 23,782 shares are held directly by Claremount VII.
Shares held directly by Thrive VII Growth and Claremount VII. Thrive Partners VII Growth GP, LLC ("Thrive Partners VII Growth") is the general partner of Thrive VII Growth. Thrive Partners VII GP, LLC ("Thrive Partners VII") is the general partner of Claremount VII. Joshua Kushner is the sole managing member of each of Thrive Partners VII Growth and Thrive Partners VII and, in his capacity as managing member, has voting and investment power over the shares held by each of Thrive VII Growth and Claremount VII. Each of the foregoing entities and Mr. Kushner disclaim beneficial ownership of the shares held of record by Thrive VII Growth and Claremount VII except to the extent of their pecuniary interest therein.
Represents (i) 54,531 shares purchased by Thrive VII Growth and (ii) 657 shares purchased by Claremount VII. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $15.12 to $15.39, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected. All shares were purchased in accordance with the daily volume and other limitations and requirements of Rule 10b-18. Following the reported transaction, 2,028,425 shares are held directly by Thrive VII Growth and 24,439 shares are held directly by Claremount VII.
Represents (i) 92,719 shares purchased by Thrive VII Growth and (ii) 1,117 shares purchased by Claremount VII. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $14.12 to $15.115, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected. All shares were purchased in accordance with the daily volume and other limitations and requirements of Rule 10b-18. Following the reported transaction, 2,121,144 shares are held directly by Thrive VII Growth and 25,556 shares are held directly by Claremount VII.
Represents (i) 209,183 shares purchased by Thrive VII Growth and (ii) 2,520 shares purchased by Claremount VII. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $15.12 to $15.81, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected. All shares were purchased in accordance with the daily volume and other limitations and requirements of Rule 10b-18. Following the reported transaction, 2,330,327 shares are held directly by Thrive VII Growth and 28,076 shares are held directly by Claremount VII.
THRIVE PARTNERS VII GROWTH GP, LLC, By: /s/ Joshua Kushner, Managing Member
2021-09-01
THRIVE CAPITAL PARTNERS VII GROWTH, L.P., By: Thrive Partners VII Growth GP, LLC, By: /s/ Joshua Kushner, Managing Member
2021-09-01
THRIVE PARTNERS VII GP, LLC, By: /s/ Joshua Kushner, Managing Member
2021-09-01
CLAREMOUNT VII ASSOCIATES, L.P., By: Thrive Partners VII GP, LLC, By: /s/ Joshua Kushner, Managing Member
2021-09-01